| 000 | 03356nam a22004095i 4500 | ||
|---|---|---|---|
| 001 | 82229 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040402.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 150116s2015 gw | s |||| 0|eng d | ||
| 020 | _a9783319117195 | ||
| 024 | 7 |
_a10.1007/978-3-319-11719-5 _2doi |
|
| 050 | 4 |
_aR853.P47 _b2015 EB |
|
| 245 | 1 | 0 |
_aIndividualized Medicine : _bEthical, Economical and Historical Perspectives _cedited by Tobias Fischer, Martin Langanke, Paul Marschall, Susanne Michl. |
| 260 |
_aCham, Switzerland _bSpringer _c2015 |
||
| 300 |
_a1 recurso en línea (XVI, 323 páginas) _b24 ilustraciones, 18 ilustraciones en color |
||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 490 | 0 |
_aAdvances in Predictive, Preventive and Personalised Medicine _x2211-3495 _v7 |
|
| 505 | 0 | _aPreface -- Introduction -- Definition and concept of Individualized Medicine -- Perspectives of socio-cultural and historical studies -- Medical perspectives -- Concept-based ethical questions -- Applied research ethics -- Health economic assessment of Individualized Medicine -- Conclusions and recommendations -- Index. | |
| 520 | 3 | _aIn 2009 the University Medicine Greifswald launched the “Greifswald Approach to Individualized Medicineâ€{u0A07}ANI_MED) to implement biomarker-based individualized diagnostic and therapeutic strategies in clinical settings. Individualized Medicine (IM) has led not only to controversies about its potentials, but also about its societal, ethical and health economic implications. ThisÂ{u1BB4}hology focusses on these areas and includes â€{u0BA5}xt to clinical examples illustrating how the integrated analysis of biomarkers leads to significant improvement of therapeutic outcomes for a subgroup of patients â€{u08E8}apters about the definition, history and epistemology of IM. Additionally there is a focus on conceptual philosophical questions as well as challenges for applied research ethics (informed consent process, the IT-based consent management and the handling of incidental findings). Finally it pays attention to health economic aspects.The possibilities of IM to initiate a paradigm shift in the German health care provision are investigated. Furthermore, it is asked whether the G-DRG system is ready for the implementation of such approaches into clinical routine. | |
| 710 | 2 |
_aSpringerLink (Online service) _0Local _9106996 |
|
| 942 |
_2lcc _cLE |
||
| 650 | 0 |
_9141658 _aEmpresas _0 |
|
| 650 | 7 |
_aToma de decisiones _0 _2embne _9141176 |
|
| 650 | 7 |
_aHistoria _0 _2embne _9138660 |
|
| 700 | 1 |
_aFischer, Tobias _eeditor literario _995020 _0Local |
|
| 700 | 1 |
_aLanganke, Martin _eeditor literario _995021 _0Local |
|
| 700 | 1 |
_aMarschall, Paul _eeditor literario _995022 _0Local |
|
| 700 | 1 |
_aMichl, Susanne _eeditor literario _995023 _0Local |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-11719-5 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 907 |
_a.b12908691 _b10-10-17 _c10-02-16 |
||
| 988 | _aSpringer_Medicine_2015 | ||
| 998 |
_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0 |
||
| 945 |
_aR853.P47 I535 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11576376 _z06-04-17 |
||
| 999 |
_c82229 _d82229 _x1 |
||